Medical
Industry Group
The NVCA formed the Medical Industry Group in 2003 in order
to better address the unique needs of members investing
in the life sciences industry. The focus of the group is
to advocate for issues important to the members of the Medical
Industry Group, conduct outreach to other industry and patient
organizations and to collect and disseminate information
about life sciences venture investing. The Medical Industry
Group staff members coordinate the group’s activities and
provide advocacy on a wide array of policy issues.
Venture investing in the life sciences (biotechnology, medical
devices, and health care services) represented approximately
30% of all venture investment. Venture backed life sciences
companies are responsible for the majority of new, innovative
therapies, devices and services that are revolutionizing
the health care industry and greatly improving the standard
of living for people around the world.
The primary goal of the Medical Industry Group is to highlight
the importance of venture capital in life sciences innovation
to policy makers, regulators and the general public. To
this end, in 2007, the NVCA released its latest edition
of Patient
Capital, a study that illustrates the crucial role VCs
play in bringing innovative therapies, devices and procedures
to the patient.
For more information about NVCA’s Medical Industry Group
contact Kelly Slone at Kslone@nvca.org
or at (703) 524-2549.
